Continuous Aerosolized Albuterol Treatment for Status Asthmaticus on the General Care Floor: A Quality Improvement

Kailey A Remien1, Charles Hardy2, Karen Allen3,4

  • 1From the Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, Ohio.

Insights

Continuous aerosolized albuterol (CAA) can be safely given on general care floors for pediatric asthma, reducing intensive care unit (PICU) hours. This quality improvement project demonstrated successful expansion of CAA use outside the PICU.

Area of Science:

  • Pediatric pulmonology
  • Quality improvement science
  • Healthcare management

Background:

  • Asthma is a major cause of pediatric hospitalization in the US.
  • Continuous aerosolized albuterol (CAA) is effective for severe asthma exacerbations but typically limited to intensive care settings.
  • Expanding CAA to general care floors can improve resource utilization.

Purpose of the Study:

  • To assess the feasibility and safety of expanding Continuous Aerosolized Albuterol (CAA) use to the general care floor (GCF) for pediatric patients with status asthmaticus.
  • To monitor treatment uptake, adherence to protocol, and safety outcomes of GCF-based CAA.
  • To evaluate the impact on Pediatric Intensive Care Unit (PICU) resource utilization.

Main Methods:

  • A single-center quality improvement project involving children aged 2-18 years with status asthmaticus.
  • Implementation of a structured protocol, staff education, and electronic health record updates.
  • Monitoring of GCF CAA hours, PICU/emergency transfers, hypotension, and ED length of stay.

Main Results:

  • Continuous aerosolized albuterol (CAA) use on the general care floor (GCF) accounted for 17% of total hospital CAA, exceeding the 10% target.
  • 72 patients were safely treated on the GCF, with 31% requiring PICU transfer (none emergent).
  • The intervention saved 1,017 PICU hours and an estimated $275,600 in costs, without increasing ED length of stay.

Conclusions:

  • Continuous aerosolized albuterol (CAA) can be safely administered on the general care floor (GCF) for pediatric asthma exacerbations.
  • A structured protocol facilitates safe GCF implementation, reducing PICU resource needs.
  • This approach optimizes resource allocation without compromising emergency department efficiency.
Abstract

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned under...